BARD® Study of LIFESTREAM™ Balloon Expandable Covered Stent Treating Iliac Arterial Occlusive Disease

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 155 participants.

Also called NCT02228564

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 155 participants (enrolled count) (from the registry)
Sponsor
  • C. R. Bard Registry lists this organization as the lead sponsor
Registry
  • NCT NCT02228564
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Germany, New Zealand (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02228564. Allocation not applicable; no masking; primary purpose treatment. Start 2014-09 (registry gives no type); primary completion 2016-12 (actual). Results posted on 2020-10-08.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
BARD® Study of LIFESTREAM™ Balloon Expandable Covered Stent Treating Iliac Arterial Occlusive Disease
Acronym
BOLSTER
Condition
Peripheral Artery Disease
Condition
Peripheral Vascular Disease
Condition
Arterial Occlusive Disease
Intervention (Procedure)
Percutaneous transluminal angioplasty (PTA)
Intervention (Device)
LIFESTREAM™ covered stent
Lead sponsor
C. R. Bard (class: industry)

Record details

Record id
cardio:ct-nct02228564
Content hash
1429ae619683eaa29073eeba9d1d8b13bcaef1c36a722d2b2438126daeb1c996